Clinical Cancer Research, 1078-0432

Tidskrift

Fler filtreringsmöjligheter
  1. 2021
  2. An Open Source, Automated Tumor Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

    Yalai Bai, Kimberly Cole, Sandra Martinez-morilla, Fahad Shabbir Ahmed, Jon Zugazagoitia, Johan Staaf, Ana Bosch-Campos, Anna Ehinger, Emma Niméus, Johan Hartman, Balazs Acs & David L Rimm, 2021 jun 4, I: Clinical Cancer Research. s. clincanres.0325.2021 clincanres.0325.2021.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. 2020
  4. Comprehensive transcriptomic profiling identifies breast cancer patients who may be spared adjuvant systemic therapy

    Martin Sjöström, S. Laura Chang, Nick Fishbane, Elai Davicioni, Linda Hartman, Erik Holmberg, Felix Y. Feng, Corey W. Speers, Lori J. Pierce, Per Malmström, Mårten Fernö & Per Karlsson, 2020 jan, I: Clinical Cancer Research. 26, 1, s. 171-182 12 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. 2019
  6. Harnessing androgen receptor pathway activation for targeted alpha particle radioimmunotherapy of breast cancer

    Daniel L.J. Thorek, Anson T. Ku, Nicholas Mitsiades, Darren Veach, Philip A. Watson, Dipti Metha, Sven Erik Strand, Sai Kiran Sharma, Jason S. Lewis, Diane S. Abou, Hans G. Lilja, Steven M. Larson, Michael R. McDevitt & David Ulmert, 2019, I: Clinical Cancer Research. 25, 2, s. 881-891 11 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. Integrated molecular analysis of undifferentiated uterine sarcomas reveals clinically relevant molecular subtypes

    Amrei Binzer-Panchal, Elin Hardell, Björn Viklund, Mehran Ghaderi, Tjalling Bosse, Marisa R. Nucci, Cheng Han Lee, Nina Hollfelder, Pádraic Corcoran, Jordi Gonzalez-Molina, Lidia Moyano-Galceran, Debra A. Bell, John K. Schoolmeester, Anna Måsbäck, Gunnar B. Kristensen, Ben Davidson, Kaisa Lehti, Anders Isaksson & Joseph W. Carlson, 2019, I: Clinical Cancer Research. 25, 7, s. 2155-2165 11 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. Proteogenomic characterization of patient-derived xenografts highlights the role of REST in neuroendocrine differentiation of castration-resistant prostate cancer

    Amilcar Flores-Morales, Tobias B. Bergmann, Charlotte Lavallee, Tanveer S. Batth, Dong Lin, Mads Lerdrup, Stine Friis, Anette Bartels, Gitte Kristensen, Agnieszka Krzyzanowska, Hui Xue, Ladan Fazli, Klaus H. Hansen, Martin A. Røder, Klaus Brasso, Jose M. Moreira, Anders Bjartell, Yuzhuo Wang, Jesper V. Olsen, Colin C. Collins & 1 andra, Diego Iglesias-Gato, 2019, I: Clinical Cancer Research. 25, 2, s. 595-608 14 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. Transcriptomic analysis reveals prognostic molecular signatures of stage I melanoma

    Rohit Thakur, Jonathan P. Laye, Martin Lauss, Joey Mark S. Diaz, Sally Jane O'Shea, Joanna Pozniak, Anastasia Filia, Mark Harland, Joanne Gascoyne, Juliette A. Randerson-Moor, May Chan, Tracey Mell, Goran Jonsson, D. Timothy Bishop, Julia Newton-Bishop, Jennifer H. Barrett & Jeremie Nsengimana, 2019, I: Clinical Cancer Research. 25, 24, s. 7424-7435 12 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. Ultrasensitive Immunoprofiling of Plasma Extracellular Vesicles Identifies Syndecan-1 as a Potential Tool for Minimally Invasive Diagnosis of Glioma

    Vineesh Indira Chandran, Charlotte Welinder, Ann-Sofie Månsson, Svenja Offer, Eva Freyhult, Maria Pernemalm, Sigrid M Lund, Shona Pedersen, Janne Lehtiö, Gyorgy Marko-Varga, Maria C Johansson, Elisabet Englund, Pia C Sundgren & Mattias Belting, 2019, I: Clinical Cancer Research. 25, 10, s. 3115-3127

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. 2018
  12. The strategy of piking a target: What is aktually most effective?

    Carlotta Costa & Ana Bosch, 2018 maj 1, I: Clinical Cancer Research. 24, 9, s. 2029-2031 3 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. 2017
  14. PAM50 provides prognostic information when applied to the lymph node metastases of advanced breast cancer patients

    Nicholas P. Tobin, Arian Lundberg, Linda S. Lindström, J. Chuck Harrell, Theodoros Foukakis, Lena Carlsson, Zakaria Einbeigi, Barbro K. Linderholm, Niklas Loman, Martin Malmberg, Mårten Fernö, Kamila Czene, Charles M. Perou, Jonas Bergh, Thomas Hatschek & TEX Trialists Group TEX Trialists Group, 2017 dec 1, I: Clinical Cancer Research. 23, 23, s. 7225-7231 7 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. In-depth genetic analysis of sclerosing epithelioid fibrosarcoma reveals recurrent genomic alterations and potential treatment targets

    Elsa Arbajian, Florian Puls, Cristina R Antonescu, Fernanda M. Amary, Raf Sciot, Maria Debiec-Rychter, Vaiyapuri Sumathi, Marcus Järås, Linda Magnusson, Jenny Nilsson, Jakob Hofvander & Fredrik Mertens, 2017 dec, I: Clinical Cancer Research. 23, 23, s. 7426-7434

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. TOP2A and EZH2 provide early detection of an aggressive prostate cancer subgroup

    David P. Labbé, Christopher J. Sweeney, Myles Brown, Phillip Galbo, Spencer Rosario, Kristine M. Wadosky, Sheng Yu Ku, Martin Sjöström, Mohammed Alshalalfa, Nicholas Erho, Elai Davicioni, R. Jeffrey Karnes, Edward M. Schaeffer, Robert B. Jenkins, Robert B. Den, Ashley E. Ross, Michaela Bowden, Ying Huang, Kathryn P. Gray, Felix Y. Feng & 4 andra, Daniel E. Spratt, David W. Goodrich, Kevin H. Eng & Leigh Ellis, 2017 nov 15, I: Clinical Cancer Research. 23, 22, s. 7072-7083 12 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. Chronic lymphocytic leukemia with mutated IGHV4-34 receptors: Shared and distinct immunogenetic features and clinical outcomes

    Aliki Xochelli, Panagiotis Baliakas, Ioannis Kavakiotis, Andreas Agathangelidis, Lesley-Ann Sutton, Eva Minga, Stavroula Ntoufa, Eugen Tausch, Xiao-Jie Yan, Tait Shanafelt, Karla Plevova, Myriam Boudjogra, Davide Rossi, Zadie Davis, Alba Navarro, Yorick Sandberg, Fie Juhl Vojdeman, Lydia Scarfo, Niki Stavroyianni, Andrey Sudarikov & 42 andra, Silvio Veronese, Tatiana Tzenou, Teodora Karan-Djurasevic, Mark Catherwood, Dirk Kienle, Maria Chatzouli, Monica Facco, Jasmin Bahlo, Christiane Pott, Lone Bredo Pedersen, Larry Mansouri, Karin E. Smedby, Charles C Chu, Veronique Giudicelli, Marie-Paule Lefranc, Panagiotis Panagiotidis, Gunnar Juliusson, Achilles Anagnostopoulos, Ioannis Vlahavas, Darko Antic, Livio Trentin, Marco Montillo, Carsten Niemann, Hartmut Dohner, Anton W Langerak, Sarka Pospisilova, Michael Hallek, Elias Campo, Nicholas Chiorazzi, Nikos Maglaveras, David Oscier, Gianluca Gaidano, Diane F. Jelinek, Stephan Stilgenbauer, Ioanna Chouvarda, Nikos Darzentas, Chrysoula Belessi, Frederic Davi, Anastasia Hadzidimitriou, Richard Rosenquist, Paolo Ghia & Kostas Stamatopoulos, 2017 sep 1, I: Clinical Cancer Research. 23, 17, s. 5292-5301 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. Clinical utility of risk modelsto refer patients with adnexal masses to specialized oncology care: Multicenter external validation using decision curve analysis

    Laure Wynants, Dirk Timmerman, Jan Y. Verbakel, Antonia Testa, Luca Savelli, Daniela Fischerova, Dorella Franchi, Caroline Van Holsbeke, Elisabeth Epstein, Wouter Froyman, Stefano Guerriero, Alberto Rossi, Robert Fruscio, Francesco P.G. Leone, Tom Bourne, Lil Valentin & Ben Van Calster, 2017 sep 1, I: Clinical Cancer Research. 23, 17, s. 5082-5090 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. A case-matched gender comparison transcriptomic screen identifies eIF4E and eIF5 as potential prognostic markers in male breast cancer

    Matthew P. Humphries, Sreekumar Sundara Rajan, Alastair Droop, Charlotte A.B. Suleman, Carmine Carbone, Cecilia Nilsson, Hedieh Honarpisheh, Gabor Cserni, Jo Dent, Laura Fulford, Lee B. Jordan, J. Louise Jones, Rani Kanthan, Maria Litwiniuk, Anna Di Benedetto, Marcella Mottolese, Elena Provenzano, Sami Shousha, Mark Stephens, Rosemary A. Walker & 12 andra, Janina Kulka, Ian O. Ellis, Margaret Jeffery, Helene H. Thygesen, Vera Cappelletti, Maria G. Daidone, Ingrid A. Hedenfalk, Marie-Louise Fjällskog, Davide Melisi, Lucy F. Stead, Abeer M. Shaaban & Valerie Speirs, 2017 maj 15, I: Clinical Cancer Research. 23, 10, s. 2575-2583 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. High-Risk Premenopausal Luminal A Breast Cancer Patients Derive no Benefit from Adjuvant Cyclophosphamide-based Chemotherapy: Results from the DBCG77B Clinical Trial

    Torsten O Nielsen, Maj-brit Jensen, Samantha Burugu, Dongxia Gao, Charlotte Levin Tykjaer Jörgensen, Eva Balslev & Bent Ejlertsen, 2017, I: Clinical Cancer Research. 23, 4, s. 946-953

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  21. Overexpression of functional SLC6A3 in clear cell renal cell carcinoma

    Jennifer Hansson, David Lindgren, Helén Nilsson, Elinn Johansson, Martin Johansson, Lena Gustavsson & Håkan Axelson, 2017, I: Clinical Cancer Research. 23, 8, s. 2105-2115

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. 2016
  23. A prospective evaluation of early detection biomarkers for ovarian cancer in the European EPIC cohort

    Kathryn L Terry, Helena Schock, Renée T Fortner, Anika Hüsing, Raina N Fichorova, Hidemi S Yamamoto, Allison F Vitonis, Theron Johnson, Kim Overvad, Anne Tjønneland, Marie-Christine Boutron-Ruault, Sylvie Mesrine, Gianluca Severi, Laure Dossus, Sabina Rinaldi, Heiner Boeing, Vassiliki Benetou, Pagona Lagiou, Antonia Trichopoulou, Vittorio Krogh & 25 andra, Elisabetta Kuhn, Salvatore Panico, H Bas Bueno-de-Mesquita, N Charlotte Onland-Moret, Petra H Peeters, Inger Torhild Gram, Elisabete Weiderpass, Eric J Duell, Maria-Jose Sanchez, Eva Ardanaz, Nerea Etxezarreta, Carmen Navarro, Annika Idahl, Eva Lundin, Karin Jirström, Jonas Manjer, Nicholas J Wareham, Kay-Tee Khaw, Karl Smith Byrne, Ruth C Travis, Marc J Gunter, Melissa A Merritt, Elio Riboli, Daniel Cramer & Rudolf Kaaks, 2016 sep 15, I: Clinical Cancer Research. 22, 18, s. 4664-4575

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. Leukemic stem cell quantification in newly diagnosed chronic myeloid leukemia patients predicts response to nilotinib therapy

    Noortje Thielen, Johan Richter, Matthias Baldauf, Gisela Barbany, Thoas Fioretos, Francis Giles, Bjørn Tore Gjertsen, Andreas Hochhaus, Gerrit Jan Schuurhuis, Sieghart Sopper, Leif Stenke, Sarah Thunberg, Dominik Wolf, Gert Ossenkoppele, Kimmo Porkka, Jeroen Janssen & Satu Mustjoki, 2016 aug 15, I: Clinical Cancer Research. 22, 16, s. 4030-4038 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. A randomized phase II/III study of naptumomab estafenatox + IFNα versus IFNα in renal cell carcinoma: Final analysis with baseline biomarker subgroup and trend analysis

    Robert E. Hawkins, Martin Gore, Yaroslav Shparyk, Vladimir Bondar, Oleg Gladkov, Tosho Ganev, Mihai Harza, Serhii Polenkov, Igor Bondarenko, Petr Karlov, Oleg Karyakin, Rustem Khasanov, Gunnar Hedlund, Göran Forsberg, Örjan Nordle & Timothy Eisen, 2016 jul 1, I: Clinical Cancer Research. 22, 13, s. 3172-3181 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  26. Changes in expression of genes representing key biologic processes after neoadjuvant chemotherapy in breast cancer, and prognostic implications in residual disease

    Marie Klintman, Richard Buus, Maggie Chon U Cheang, Amna Sheri, Ian E. Smith & Mitch Dowsett, 2016 maj 15, I: Clinical Cancer Research. 22, 10, s. 2405-2416 12 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. Transcriptional profiling of breast cancer metastases identifies liver metastasis-selective genes associated with adverse outcome in luminal A primary breast cancer.

    Siker Kimbung, Ida Johansson, Anna Danielsson, Srinivas Veerla, Suzanne Egyhazi Brage, Marianne Frostvik Stolt, Lambert Skoog, Lena Carlsson, Zakaria Einbeigi, Elisabet Lidbrink, Barbro Kristina Linderholm, Niklas Loman, Per Malmström, Martin Söderberg, Thomas M Walz, Mårten Fernö, Thomas Hatschek & Ingrid Hedenfalk, 2016, I: Clinical Cancer Research. 22, 1, s. 146-157

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  28. 2015
  29. Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer

    Francisco J Candido-dos-Reis, Honglin Song, Ellen L Goode, Julie M Cunningham, Brooke L Fridley, Melissa C Larson, Kathryn Alsop, Ed Dicks, Patricia Harrington, Susan J Ramus, Anna de Fazio, Gillian Mitchell, Sian Fereday, Kelly L Bolton, Charlie Gourley, Caroline Michie, Beth Karlan, Jenny Lester, Christine Walsh, Ilana Cass & 31 andra, Håkan Olsson, Martin Gore, Javier J Benitez, Maria J Garcia, Irene Andrulis, Anna Marie Mulligan, Gord Glendon, Ignacio Blanco, Conxi Lazaro, Alice S Whittemore, Valerie McGuire, Weiva Sieh, Marco Montagna, Elisa Alducci, Siegal Sadetzki, Angela Chetrit, Ava Kwong, Susanne K Kjaer, Allan Jensen, Estrid Høgdall, Susan Neuhausen, Robert Nussbaum, Mary Daly, Mark H Greene, Phuong L Mai, Jennifer T Loud, Kirsten Moysich, Amanda E Toland, Diether Lambrechts, Steve Ellis & EMBRACE EMBRACE, 2015 feb 1, I: Clinical Cancer Research. 21, 3, s. 652-7 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  30. A phase 1 dose-escalation study of antibody BI-505 in relapsed/refractory multiple myeloma.

    Markus Hansson, Peter Gimsing, Ashraf Z Badros, Titti Martinsson Niskanen, Hareth Nahi, Fritz Offner, Morten Salomo, Elisabeth Sonesson, Morten Mau-Sorensen, Yvonne Stenberg, Annika Sundberg, Ingrid Teige, Jan van Droogenbroeck, Stina Wichert, Maurizio Zangari, Bjorn Frendeus, Magnus Korsgren, Martine Poelman & Guido Tricot, 2015, I: Clinical Cancer Research. 21, 12, s. 2730-2736

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  31. Caffeine and caffeic acid inhibit growth and modify estrogen receptor (ER) and insulin-like growth factor I receptor (IGF-IR) levels in human breast cancer.

    Ann Rosendahl, Claire M Perks, Li Zeng, Andrea Markkula, Maria Simonsson, Carsten Rose, Christian Ingvar, Jeff Mp Holly & Helena Jernström, 2015, I: Clinical Cancer Research. 21, 8, s. 1877-1887

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  32. Global transcriptional changes following statin treatment in breast cancer.

    Olöf Bjarnadottir, Siker Kimbung, Ida Johansson, Srinivas Veerla, Mats Jönsson, Pär-Ola Bendahl, Dorthe Grabau, Ingrid Hedenfalk & Signe Borgquist, 2015, I: Clinical Cancer Research. 21, 15, s. 3402-3411

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  33. Recurrent PRDM10 Gene Fusions in Undifferentiated Pleomorphic Sarcoma.

    Jakob Hofvander, Johnbosco Tayebwa, Jenny Nilsson, Linda Magnusson, Otte Brosjö, Olle L Larsson, Fredrik Vult von Steyern, Nils Mandahl, Christopher Fletcher & Fredrik Mertens, 2015, I: Clinical Cancer Research. 21, 4, s. 864-869

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  34. The human agonistic CD40 antibody ADC-1013 eradicates bladder tumors and generates T cell dependent tumor immunity.

    Sara M Mangsbo, Sissela Broos, Erika Fletcher, Niina Veitonmaki, Christina Furebring, Eva Dahlen, Per Norlén, Malin Lindstedt, Thomas H Totterman & Peter Ellmark, 2015, I: Clinical Cancer Research. 21, 5, s. 1115-1126

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  35. 2014
  36. Human anaplastic thyroid carcinoma cells are sensitive to NK cell-mediated lysis via ULBP2/5/6 and chemoattract NK cells

    Erik Wennerberg, Aline Pfefferle, Lars Ekblad, Yuya Yoshimoto, Veronika Kremer, Vitaliy O Kaminskyy, C Christofer Juhlin, Anders Höög, Inger Bodin, Vitalijs Svjatoha, Catharina Larsson, Jan Zedenius, Johan Wennerberg & Andreas Lundqvist, 2014 nov 15, I: Clinical Cancer Research. 20, 22, s. 5733-44 12 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  37. Increased KIT inhibition enhances therapeutic efficacy in gastrointestinal stromal tumor

    M.J. Cavnar, T.S. Kim, N.A. Cohen, E.C. Sorenson, J.B. Greer, A.M. Seifert, B.L. Green, R. Popow, N. Pillarsetty, D.R. Veach, Anson Ku, F. Rossi, P. Besmer, C.R. Antonescu, S. Zeng & R.P. De Matteo, 2014 maj 1, I: Clinical Cancer Research. 20, 9

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  38. Genomic and transcriptional alterations in lung adenocarcinoma in relation to smoking history.

    Anna K Karlsson, Markus Ringnér, Martin Lauss, Johan Botling, Patrick Micke, Maria Planck & Johan Staaf, 2014, I: Clinical Cancer Research. 20, 18, s. 4912-4924

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  39. 2013
  40. Expression Defect Size among Unclassified MLH1 Variants Determines Pathogenicity in Lynch Syndrome Diagnosis

    Inga Hinrichsen, Angela Brieger, Joerg Trojan, Stefan Zeuzem, Mef Nilbert & Guido Plotz, 2013, I: Clinical Cancer Research. 19, 9, s. 2432-2441

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  41. Vemurafenib Synergizes with Nutlin-3 to Deplete Survivin and Suppresses Melanoma Viability and Tumor Growth

    Zhenyu Ji, Raj Kumar, Michael Taylor, Anpuchchelvi Rajadurai, Alexander Marzuka-Alcala, Y. Erin Chen, Ching-Ni Jenny Njauw, Keith Flaherty, Göran B Jönsson & Hensin Tsao, 2013, I: Clinical Cancer Research. 19, 16, s. 4383-4391

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  42. 2012
  43. A Molecular Taxonomy for Urothelial Carcinoma.

    Gottfrid Sjödahl, Martin Lauss, Kristina Lövgren, Gunilla Chebil, Sigurdur Gudjonsson, Srinivas Veerla, Oliver Hultman Patschan, Mattias Aine, Mårten Fernö, Markus Ringnér, Wiking Månsson, Fredrik Liedberg, David Lindgren & Mattias Höglund, 2012, I: Clinical Cancer Research. 18, 12, s. 3377-3386

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  44. Cytoplasmic Estrogen Receptor in Breast Cancer

    Allison W. Welsh, Donald R. Lannin, Gregory S. Young, Mark E. Sherman, Jonine D. Figueroa, N. Lynn Henry, Lisa Rydén, Chungyeul Kim, Richard R. Love, Rachel Schiff & David L. Rimm, 2012, I: Clinical Cancer Research. 18, 1, s. 118-126

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  45. Expression of Cocaine- and Amphetamine-Regulated Transcript Is Associated with Worse Survival in Small Bowel Carcinoid Tumors

    Kalle Landerholm, Liliya Shcherbina, Sture E. Falkmer, Johannes Jarhult & Nils Wierup, 2012, I: Clinical Cancer Research. 18, 13, s. 3668-3676

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  46. External Validation of Diagnostic Models to Estimate the Risk of Malignancy in Adnexal Masses

    Caroline Van Holsbeke, Ben Van Calster, Tom Bourne, Silvia Ajossa, Antonia C. Testa, Stefano Guerriero, Robert Fruscio, Andrea Alberto Lissoni, Artur Czekierdowski, Luca Savelli, Sabine Van Huffel, Lil Valentin & Dirk Timmerman, 2012, I: Clinical Cancer Research. 18, 3, s. 815-825

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  47. miR-187 Is an Independent Prognostic Factor in Breast Cancer and Confers Increased Invasive Potential In Vitro

    Laoighse Mulrane, Stephen F. Madden, Donal J. Brennan, Gabriela Gremel, Sharon F. McGee, Sara McNally, Finian Martin, John P. Crown, Karin Jirström, Desmond G. Higgins, William M. Gallagher & Darran P. O'Connor, 2012, I: Clinical Cancer Research. 18, 24, s. 6702-6713

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  48. Molecular profiling reveals low- and high-grade forms of primary melanoma

    Katja Harbst, Johan Staaf, Martin Lauss, Anna Karlsson, Anna Måsbäck, Iva Johansson, Pär-Ola Bendahl, Johan Vallon-Christersson, Therese Törngren, Henrik Ekedahl, Jurgen Geisler, Mattias Höglund, Markus Ringnér, Lotta Lundgren, Karin Jirström, Håkan Olsson, Christian Ingvar, Åke Borg, Hensin Tsao & Göran B Jönsson, 2012, I: Clinical Cancer Research. 18, 15, s. 4026-4036

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  49. The Rectal Cancer microRNAome - microRNA Expression in Rectal Cancer and Matched Normal Mucosa.

    Jochen Gaedcke, Marian Grade, Jordi Camps, Rolf Sökilde, Bogumil Kaczkowski, Aaron J Schetter, Michael J Difilippantonio, Curtis C Harris, B Michael Ghadimi, Søren Møller, Tim Beissbarth, Thomas Ried & Thomas Litman, 2012, I: Clinical Cancer Research. 18, 18, s. 4919-4930

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  50. 2011
  51. Prospective analysis of parametric response map-derived MRI biomarkers: identification of early and distinct glioma response patterns not predicted by standard radiographic assessment

    Craig J Galbán, Thomas L Chenevert, Charles R Meyer, Christina Tsien, Theodore S Lawrence, Daniel A Hamstra, Larry Junck, Pia C Sundgren, Timothy D Johnson, Stefanie Galbán, Judith S Sebolt-Leopold, Alnawaz Rehemtulla & Brian D Ross, 2011 jul 15, I: Clinical Cancer Research. 17, 14, s. 4751-60 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  52. FUS-CREB3L2/L1-Positive Sarcomas Show a Specific Gene Expression Profile with Upregulation of CD24 and FOXL1.

    Emely Möller, Jason L Hornick, Linda Magnusson, Srinivas Veerla, Henryk Domanski & Fredrik Mertens, 2011, I: Clinical Cancer Research. 17, 9, s. 2646-2656

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Föregående 1 2 3 Nästa